Stroke, not specified as haemorrhage or infarctio
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who suffered a stroke (type 1); patients who have severe hemeparesis as a consequence of the stroke; both female and male patients; patients above 18 years old
Exclusion criteria
Exclusion criteria: Patients who have any type of metal inside their body (pins, pacemakers, metal prostheses, revolver bullets); patients who have any musculoskeletal injury on the affected or unaffected limbs; patients who had previous conditions such as seizures, head trauma, hearing problems and cochlear impalants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect that differences will occur among conditions, in which conditions (iii) and (iV) will lead to greater increases in strength, power, muscle activation and active range of motion of the paretic limbs from before to after the intervention compared to the other conditions;We expect that differences will occur among conditions, in which condition (iii) and (iv) will lead to greater increases in cortical connectivity and corticospinal excitability, and reductions in pre-synaptic and intracortical inhibition, which will facilitate the neural pathway for motor gains to occur on the paretic muscle groups from before to after the intervention compared to the other conditions | — |
Secondary
| Measure | Time frame |
|---|---|
| We expect that differences will occur among conditions, in which conditions (iii) and (iv) will lead to greater changes on the same parameters assessed on the non-paretic limbs from before to after the intervention compared to the other conditions;We expect the greatest changes to occur for all measurements when tDCS is applied on the motor cortex hemisphere not affected (contralesionsal) by the stroke episode | — |
Countries
Australia, Brazil
Contacts
Universidade Estadual de Campinas